The role of caveolin-1 in androgen insensitive prostate cancer

被引:66
作者
Mouraviev, V [1 ]
Li, LK
Tahir, SA
Yang, G
Timme, TL
Goltsov, A
Ren, CZ
Satoh, T
Wheeler, TM
Ittmann, MM
Miles, BJ
Amato, RJ
Kadmon, D
Thompson, TC
机构
[1] Baylor Coll Med, Vet Affairs Med Ctr, Scott Dept Urol, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Cell & Mol Biol, Houston, TX 77030 USA
[4] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA
关键词
prostate; prostatic neoplasms; caveolins; neoplasm metastasis; androgens;
D O I
10.1016/S0022-5347(05)64526-0
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We summarize the literature regarding androgen insensitive prostate cancer and caveolin-1. Caveolin-1 is a major structural component of caveolae, membrane micro-domains known to have important roles in signal transduction and lipid transport. Materials and Methods: A review of the literature relevant to androgen insensitive caveolin-1 and prostate cancer included the first published report in 1998 through those published in March 2002. Results: Caveolin-1 expression is increased in primary and metastatic human prostate cancer with highest levels observed after androgen ablation therapy. Recent studies have documented that caveolin-1 is secreted by prostate cancer cells and can be detected in the serum of men with prostate cancer. Conclusions: The results presented in this review establish that caveolin-1 is an autocrine/paracrine factor associated with androgen insensitive prostate cancer. They show the potential for caveolin-1 as a biomarker therapeutic target for this important malignancy.
引用
收藏
页码:1589 / 1596
页数:8
相关论文
共 80 条
[41]   Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy [J].
Minetti, C ;
Sotgia, F ;
Bruno, C ;
Scartezzini, P ;
Broda, P ;
Bado, M ;
Masetti, E ;
Mazzocco, M ;
Egeo, A ;
Donati, MA ;
Volonté, D ;
Galbiati, F ;
Cordone, G ;
Bricarelli, FD ;
Lisanti, MP ;
Zara, F .
NATURE GENETICS, 1998, 18 (04) :365-368
[42]   Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling [J].
Mousses, S ;
Wagner, U ;
Chen, YD ;
Kim, JW ;
Bubendorf, L ;
Bittner, M ;
Pretlow, T ;
Elkahloun, AG ;
Trepel, JB ;
Kallioniemi, OP .
ONCOGENE, 2001, 20 (46) :6718-6723
[43]   Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state [J].
Murillo, H ;
Huang, HJ ;
Schmidt, LJ ;
Smith, DI ;
Tindall, DJ .
ENDOCRINOLOGY, 2001, 142 (11) :4795-4805
[44]   Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells [J].
Nasu, Y ;
Timme, TL ;
Yang, G ;
Bangma, CH ;
Li, LK ;
Ren, CZ ;
Park, SH ;
DeLeon, M ;
Wang, JX ;
Thompson, TC .
NATURE MEDICINE, 1998, 4 (09) :1062-1064
[45]   Genetic alterations in hormone-refractory recurrent prostate carcinomas [J].
Nupponen, NN ;
Kakkola, L ;
Koivisto, P ;
Visakorpi, T .
AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (01) :141-148
[46]   CAN RADICAL PROSTATECTOMY ALTER THE PROGRESSION OF POORLY DIFFERENTIATED PROSTATE-CANCER [J].
OHORI, M ;
GOAD, JR ;
WHEELER, TM ;
EASTHAM, JA ;
THOMPSON, TC ;
SCARDINO, PT .
JOURNAL OF UROLOGY, 1994, 152 (05) :1843-1849
[47]  
Osman I, 2001, CLIN CANCER RES, V7, P2643
[48]   Isolated endosomes from quiescent rat liver contain the signal transduction machinery - Differential distribution of activated Raf-1 and Mek in the endocytic compartment [J].
Pol, A ;
Calvo, M ;
Enrich, C .
FEBS LETTERS, 1998, 441 (01) :34-38
[49]  
QIAN JQ, 1995, CANCER RES, V55, P5408
[50]   Caveolin-1 expression is associated with high-grade bladder cancer [J].
Rajjayabun, PH ;
Garg, S ;
Durkan, GC ;
Charlton, R ;
Robinson, MC ;
Mellon, JK .
UROLOGY, 2001, 58 (05) :811-814